Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice.

Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice.

Respiratory Syncytial Virus (RSV) is a major cause of viral brochiolitis in infants and young children and is also a significant problem in elderly and immuno-compromised adults. To date there is no efficacious and safe RSV vaccine, partially because of the outcome of a clinical trial in the 1960s w...

Full description

Bibliographic Details
Main Authors:	Tobias Kamphuis, Tjarko Meijerhof, Toon Stegmann, Julia Lederhofer, Jan Wilschut, Aalzen de Haan
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3348902?pdf=render

Similar Items

Evaluation of an intranasal virosomal vaccine against respiratory syncytial virus in mice: effect of TLR2 and NOD2 ligands on induction of systemic and mucosal immune responses.
by: Muhammad Shafique, et al.
Published: (2013-01-01)

Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
by: Natalija Budimir, et al.
Published: (2012-01-01)

Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge.
by: Soojin Park, et al.
Published: (2018-01-01)

Dual role of respiratory syncytial virus glycoprotein fragment as a mucosal immunogen and chemotactic adjuvant.
by: Sol Kim, et al.
Published: (2012-01-01)

Cell recruitment and cytokines in skin mice sensitized with the vaccine adjuvants: saponin, incomplete Freund's adjuvant, and monophosphoryl lipid A.
by: Juliana Vitoriano-Souza, et al.
Published: (2012-01-01)

Immunogenicity of a virosomally-formulated <it>Plasmodium falciparum </it>GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations
by: Tamborrini Marco, et al.
Published: (2011-12-01)

Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models
by: Badiaa Bouzya, et al.
Published: (2023-09-01)

Immuno-Stimulatory Activity of Escherichia coli Mutants Producing Kdo2-Monophosphoryl-Lipid A or Kdo2-Pentaacyl-Monophosphoryl-Lipid A.
by: Biwen Wang, et al.
Published: (2015-01-01)

Virosome: A vector in vaccine delivery
by: Karpe Shubham, et al.
Published: (2024-01-01)

Virosome: An engineered virus for vaccine delivery
by: Hasan Ali, et al.
Published: (2023-05-01)

Monophosphoryl Lipid A and Poly I:C Combination Adjuvant Promoted Ovalbumin-Specific Cell Mediated Immunity in Mice Model
by: So Yeon Ahn, et al.
Published: (2021-09-01)

Russian virosomal vaccine Efficacy and safety evaluation
by: T. A. Grenkova, et al.
Published: (2015-12-01)

Adjuvant effects of combination monophosphoryl lipid A and poly I:C on antigen-specific immune responses and protective efficacy of influenza vaccines
by: Chau Thuy Tien Le, et al.
Published: (2023-07-01)

Study on the CID Fragmentation Pathways of Deprotonated 4’-Monophosphoryl Lipid A
by: Ibrahim Aissa, et al.
Published: (2021-10-01)

Inefficient TLR4/MD-2 heterotetramerization by monophosphoryl lipid A.
by: Carolyn R Casella, et al.
Published: (2013-01-01)

Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates
by: Ariel Isaacs, et al.
Published: (2021-09-01)

Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer
by: Debra Wu, et al.
Published: (2021-01-01)

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.
by: Felix Geeraedts, et al.
Published: (2008-08-01)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
by: Green, C, et al.
Published: (2015)

Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus.
by: Jeffrey C Boyington, et al.
Published: (2016-01-01)

A Comparison of Intramuscular and Subcutaneous Administration of LigA Subunit Vaccine Adjuvanted with Neutral Liposomal Formulation Containing Monophosphoryl Lipid A and QS21
by: Teerasit Techawiwattanaboon, et al.
Published: (2020-09-01)

Functional NK Cell Activation by Ovalbumin Immunization with a Monophosphoryl Lipid A and Poly I:C Combination Adjuvant Promoted Dendritic Cell Maturation
by: Chau Thuy Tien Le, et al.
Published: (2021-09-01)

Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate
by: Bárbara Fernandes, et al.
Published: (2022-04-01)

A Triple Co-Culture Model of the Human Respiratory Tract to Study Immune-Modulatory Effects of Liposomes and Virosomes.
by: Rebecca A M Blom, et al.
Published: (2016-01-01)

The Virosome as a Novel Concept for High Pathogenic Porcine Reproductive and Respiratory Syndrome Virus (HP-PRRSV) Vaccines
by: Zheng CAO, et al.
Published: (2013-07-01)

Enhanced Immunogenicity and Protective Efficacy of a <italic toggle="yes">Campylobacter jejuni</italic> Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21
by: Amritha Ramakrishnan, et al.
Published: (2019-06-01)

Dynamics of the bacterially expressed conserved immunogenic region of the human respiratory syncytial virus G protein.
by: Jalilian, Farid Azizi, et al.
Published: (2011)

Immunogenicity of a recombinant plant-produced respiratory syncytial virus F subunit vaccine in mice
by: Nuttapat Pisuttinusart, et al.
Published: (2024-03-01)

Refining the Balance of Attenuation and Immunogenicity of Respiratory Syncytial Virus by Targeted Codon Deoptimization of Virulence Genes
by: Jia Meng, et al.
Published: (2014-10-01)

A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike
by: Yme U. van der Velden, et al.
Published: (2022-03-01)

Synthesis of monophosphorylated lipid A precursors using 2-naphthylmethyl ether as a protecting group
by: Jundi Xue, et al.
Published: (2020-08-01)

An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice
by: Cherukuri Anu, et al.
Published: (2012-10-01)

Enhancement of the immunogenicity and protective efficacy of a mucosal influenza subunit vaccine by the saponin adjuvant GPI-0100.
by: Heng Liu, et al.
Published: (2012-01-01)

Construction of Monophosphoryl Lipid A Producing Escherichia coli Mutants and Comparison of Immuno-Stimulatory Activities of Their Lipopolysaccharides
by: Feng Guan, et al.
Published: (2013-01-01)

In Vitro Evaluation of the Biological Responses of Canine Macrophages Challenged with PLGA Nanoparticles Containing Monophosphoryl Lipid A.
by: Delphine Guldner, et al.
Published: (2016-01-01)

Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.
by: Geert Leroux-Roels, et al.
Published: (2013-01-01)

Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency
by: Mohamed A. Farrag, et al.
Published: (2017-07-01)

Protective efficacy and immunogenicity of a combinatory DNA vaccine against Influenza A Virus and the Respiratory Syncytial Virus.
by: Viktoria Stab, et al.
Published: (2013-01-01)

Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine
by: Francisco Noé Fonseca, et al.
Published: (2023-08-01)

Reconstruction of H3N2 influenza virus based virosome in-vitro
by: Asghar Abdoli, et al.
Published: (2013-06-01)